Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLF – Get Free Report)’s stock price reached a new 52-week low during trading on Tuesday . The company traded as low as $11.64 and last traded at $11.64, with a volume of 7500 shares trading hands. The stock had previously closed at $11.64.
Ono Pharmaceutical Stock Performance
The firm has a market capitalization of $5.98 billion, a P/E ratio of 8.69 and a beta of 0.55. The company’s fifty day moving average is $13.93 and its 200-day moving average is $14.11.
About Ono Pharmaceutical
Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.
Featured Articles
- Five stocks we like better than Ono Pharmaceutical
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Palantir Cracks $50, Is There Still Time to Get on Board?
- Consumer Discretionary Stocks Explained
- Insider Buying Signals Upside for These 3 Stocks
- How Can Investors Benefit From After-Hours Trading
- These 2 Big Players Are Set to Compete With Elon Musk’s Starlink
Receive News & Ratings for Ono Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ono Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.jpg?v=20220629090309&h=45&w=95&zc=2){kind=logo}